End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.05 CNY | +0.82% |
|
-2.01% | -37.38% |
Business Summary
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Liver-protecting Drugs
48.0
%
| 178 | 46.1 % | 203 | 48.0 % | +13.94% |
Anti-hepatitis B Virus Drugs
28.8
%
| 155 | 40.2 % | 122 | 28.8 % | -21.54% |
Cardiovascular Drugs
8.4
%
| 22 | 5.8 % | 36 | 8.4 % | +58.14% |
Anti-coronavirus Drugs
5.0
%
| - | - | 21 | 5.0 % | - |
Digestive System Drugs
4.5
%
| 18 | 4.8 % | 19 | 4.5 % | +2.25% |
Men's Health Products
2.5
%
| 3 | 0.7 % | 10 | 2.5 % | +314.68% |
Other
2.2
%
| 6 | 1.6 % | 9 | 2.2 % | +56.44% |
Respiratory Drugs
0.7
%
| 3 | 0.9 % | 3 | 0.7 % | -6.31% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 386 | 100.0 % | 423 | 100.0 % | +9.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Guo Ping Li
CEO | Chief Executive Officer | 56 | 28/01/28 |
Jian Hui Guan
DFI | Director of Finance/CFO | 48 | 25/17/25 |
Yuan Li Li
CHM | Chairman | 66 | 01/11/01 |
Hong Ming Li
COO | Chief Operating Officer | 55 | 06/21/06 |
Fu hu Huang
BRD | Director/Board Member | 48 | 20/16/20 |
Guo Dong Li
BRD | Director/Board Member | 53 | 01/02/01 |
Yang Ding
IRC | Investor Relations Contact | 42 | - |
Qing He Zhang
PRN | Corporate Officer/Principal | - | 04/23/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Ping Li
CEO | Chief Executive Officer | 56 | 28/01/28 |
Li Qing Ye
BRD | Director/Board Member | 54 | 20/11/20 |
Guo Dong Li
BRD | Director/Board Member | 53 | 01/02/01 |
Yuan Li Li
CHM | Chairman | 66 | 01/11/01 |
Hong Ren
BRD | Director/Board Member | 64 | 06/21/06 |
Fu hu Huang
BRD | Director/Board Member | 48 | 20/16/20 |
Xiao Yang Guo
BRD | Director/Board Member | 56 | 23/21/23 |
Ming Yu Chen
BRD | Director/Board Member | 61 | 20/17/20 |
Xin Rong Qiang
BRD | Director/Board Member | 52 | 20/17/20 |
Hong Ming Li
COO | Chief Operating Officer | 55 | 06/21/06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 159,267,000 | 80,116,648 ( 50.30 %) | 0 | 50.30 % |
Company contact information
Fujian Cosunter Pharmaceutical Co., Ltd.
Bldg16, Phase II, Innovation Park No. 7 Wulongjiang Middle Avenue
350108, Fuzhou
+
http://www.cosunter.com![address Fujian Cosunter Pharmaceutical Co., Ltd.(300436)](https://cdn.zonebourse.com/static/address/27329635.png)
Sector
Sales per Business
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.38% | 352M | |
+51.99% | 798B | |
-5.72% | 356B | |
+18.94% | 328B | |
+11.07% | 304B | |
+16.96% | 244B | |
+2.25% | 227B | |
+11.15% | 216B | |
+7.59% | 166B | |
-3.65% | 157B |
- Stock Market
- Equities
- 300436 Stock
- Company Fujian Cosunter Pharmaceutical Co., Ltd.